Skip to main content
Log in

Haemodynamic changes in hepatocellular carcinoma and liver parenchyma under balloon occlusion of the hepatic artery

  • Interventional
  • Published:
European Radiology Aims and scope Submit manuscript

Abstract

Objectives

To investigate haemodynamic changes in hepatocellular carcinoma (HCC) and liver under hepatic artery occlusion.

Methods

Thirty-eight HCC nodules in 25 patients were included. Computed tomography (CT) during hepatic arteriography (CTHA) with and without balloon occlusion of the hepatic artery was performed. CT attenuation and enhancement volume of HCC and liver with and without balloon occlusion were measured on CTHA. Influence of balloon position (segmental or subsegmental branch) was evaluated based on differences in HCC-to-liver attenuation ratio (H/L ratio) and enhancement volume of HCC and liver.

Results

In the segmental group (n = 20), H/L ratio and enhancement volume of HCC and liver were significantly lower with balloon occlusion than without balloon occlusion. However, in the subsegmental group (n = 18), H/L ratio was significantly higher and liver enhancement volume was significantly lower with balloon occlusion; HCC enhancement volume was similar with and without balloon occlusion. Rate of change in H/L ratio and enhancement volume of HCC and liver were lower in the segmental group than in the subsegmental group. There were significantly more perfusion defects in HCC in the segmental group.

Conclusions

Hepatic artery occlusion causes haemodynamic changes in HCC and liver, especially with segmental occlusion.

Key Points

Hepatic artery occlusion causes haemodynamic changes in hepatocellular carcinoma and liver.

Segmental occlusion decreased rate of change in hepatocellular carcinoma-to-liver attenuation ratio.

Subsegmental occlusion increased rate of change in hepatocellular carcinoma-to-liver attenuation ratio.

Hepatic artery occlusion decreased enhancement volume of hepatocellular carcinoma and liver.

Hepatic artery occlusion causes perfusion defects in hepatocellular carcinoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Abbreviations

B-TACE:

Balloon-occluded transarterial chemoembolization

CT:

Computed tomography

CTHA:

Computed tomography hepatic arteriography

HCC:

Hepatocellular carcinoma

H/L:

Hepatocellular carcinoma to liver parenchyma attenuation ratio

HU:

Hounsfield units

TACE:

Transarterial chemoembolization

References

  1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69–90

    Article  PubMed  Google Scholar 

  2. Llovet JM, Brú C, Bruix J (1999) Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 19:329–338

    Article  CAS  PubMed  Google Scholar 

  3. Forner A, Llovet JM, Bruix J (2012) Hepatocellular carcinoma. Lancet 379:1245–1255

    Article  PubMed  Google Scholar 

  4. European Association for the Study of the Liver, European Organisation for Research and Treatment of Cancer (2012) EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 56:908–943

    Article  Google Scholar 

  5. Bruix J, Sherman M, Practice Guidelines Committee, American Association for the Study of Liver Diseases (2005) Management of hepatocellular carcinoma. Hepatology 42:1208–1236

    Article  PubMed  Google Scholar 

  6. Cammà C, Schepis F, Orlando A et al (2002) Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials. Radiology 224:47–54

    Article  PubMed  Google Scholar 

  7. Lo CM, Ngan H, Tso WK et al (2002) Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 35:1164–1171

    Article  CAS  PubMed  Google Scholar 

  8. Llovet JM, Bruix J (2003) Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 37:429–442

    Article  CAS  PubMed  Google Scholar 

  9. Yamada R, Yamaguchi S, Nakatsuka H et al (1981) Balloon-occluded arterial infusion--a new method for administration of anticancer drugs [in Japanese]. Nihon Igaku Hoshasen Gakkai Zasshi 41:894–896

    CAS  PubMed  Google Scholar 

  10. Ishizaka H, Ishijima H, Katsuya T, Horikoshi H, Koyama Y (1997) Compulsory superselective arterial embolization in hypovascular local hepatic tumor ablation. Microballoon coaxial catheterization. Acta Radiol 38:836–839

    CAS  PubMed  Google Scholar 

  11. Irie T, Kuramochi M, Takahashi N (2013) Dense accumulation of lipiodol emulsion in hepatocellular carcinoma nodule during selective balloon-occluded transarterial chemoembolization: measurement of balloon-occluded arterial stump pressure. Cardiovasc Intervent Radiol 36:706–713

    Article  PubMed  Google Scholar 

  12. Ishikawa T, Abe S, Inoue R et al (2014) Predictive factor of local recurrence after balloon-occluded TACE with miriplatin (MPT) in hepatocellular carcinoma. PLoS One 9, e103009

    Article  PubMed  PubMed Central  Google Scholar 

  13. Arai H, Abe T, Takayama H et al (2015) Safety and efficacy of balloon-occluded transcatheter arterial chemoembolization using miriplatin for hepatocellular carcinoma. Hepatol Res 45:663–666

    Article  CAS  PubMed  Google Scholar 

  14. Murata S, Mine T, Sugihara F et al (2014) Interventional treatment for unresectable hepatocellular carcinoma. World J Gastroenterol 20:13453–13465

    Article  PubMed  PubMed Central  Google Scholar 

  15. Michels NA (1966) Newer anatomy of the liver and its variant blood supply and collateral circulation. Am J Surg 112:337–347

    Article  CAS  PubMed  Google Scholar 

  16. Takeuchi Y, Arai Y, Inaba Y, Ohno K, Maeda T, Itai Y (1998) Extrahepatic arterial supply to the liver: observation with a unified CT and angiography system during temporary balloon occlusion of the proper hepatic artery. Radiology 209:121–128

    Article  CAS  PubMed  Google Scholar 

  17. Tohma T, Cho A, Okazumi S et al (2005) Communicating arcade between the right and left hepatic arteries: evaluation with CT and angiography during temporary balloon occlusion of the right or left hepatic artery. Radiology 237:361–365

    Article  PubMed  Google Scholar 

  18. Murata S, Tajima H, Abe Y et al (2005) Transcatheter management for multiple liver tumors after hepatic artery obstruction following reservoir placement. Hepatogastroenterology 52:852–856

    PubMed  Google Scholar 

  19. Koehler RE, Korobkin M, Lewis F (1975) Arteriographic demonstration of collateral arterial supply to the liver after hepatic artery ligation. Radiology 117:49–54

    Article  CAS  PubMed  Google Scholar 

  20. Itai Y, Moss AA, Goldberg HI (1982) Transient attenuation difference of lobar or segmental distribution detected by dynamic computed tomography. Radiology 144:835–839

    Article  CAS  PubMed  Google Scholar 

  21. Itai Y, Murata S, Kurosaki Y (1995) Straight border sign of the liver: spectrum of CT appearances and causes. Radiographics 15:1089–1102

    Article  CAS  PubMed  Google Scholar 

  22. Lautt WW, Legare DJ, Ezzat WR (1990) Quantitation of the hepatic arterial buffer response to graded changes in portal blood flow. Gastroenterology 98:1024–1028

    Article  CAS  PubMed  Google Scholar 

  23. Jakab F, Ráth Z, Schmal F, Nagy P, Faller J (1995) The interaction between hepatic arterial and portal venous blood flows; simultaneous measurement by transit time ultrasonic volume flowmetry. Hepatogastroenterology 42:18–21

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The scientific guarantor of this publication is Satoru Murata. The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article. The authors state that this work has not received any funding. No complex statistical methods were necessary for this paper. Institutional Review Board approval was obtained. Written informed consent was obtained from all patients in this study. None of the study subjects or cohorts have been previously reported. Methodology: prospective, observational, performed at one institution.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Satoru Murata.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sugihara, F., Murata, S., Ueda, T. et al. Haemodynamic changes in hepatocellular carcinoma and liver parenchyma under balloon occlusion of the hepatic artery. Eur Radiol 27, 2474–2481 (2017). https://doi.org/10.1007/s00330-016-4573-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-016-4573-2

Keywords

Navigation